Profile data is unavailable for this security.
About the company
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
- Revenue in INR (TTM)7.48bn
- Net income in INR325.59m
- Incorporated2015
- Employees68.00
- LocationRemus Pharmaceuticals Ltd11th Floor, South Tower,One42, Near Ashok Vatika, Bopal-Ambli RoAHMEDABAD 380058IndiaIND
- Phone+91 7 929999857
- Websitehttps://remuspharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kilitch Drugs (India) Ltd | 2.07bn | 264.30m | 5.60bn | 187.00 | 20.19 | -- | 20.10 | 2.70 | 15.87 | 15.87 | 123.46 | -- | -- | -- | -- | 11,074,770.00 | -- | 5.16 | -- | 7.38 | 35.29 | 35.37 | 12.18 | 8.41 | -- | 4.54 | -- | 0.00 | 28.47 | 30.05 | 82.86 | 99.64 | 34.88 | -- |
| Shri Ahimsa Naturals Ltd | 1.16bn | 266.73m | 6.06bn | -- | 17.65 | 3.57 | 21.24 | 5.24 | 14.65 | 14.65 | 61.23 | 72.37 | 0.7957 | 1.80 | 4.75 | -- | 18.36 | 25.55 | 19.42 | 31.51 | 48.63 | 53.50 | 23.07 | 25.19 | 12.68 | -- | 0.00 | -- | 22.86 | 34.75 | 17.31 | 78.70 | 53.34 | -- |
| Anlon Healthcare Ltd | 1.70bn | 346.64m | 6.39bn | 101.00 | 16.32 | -- | 17.41 | 3.76 | 7.37 | 7.37 | 37.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 38.31 | -- | 20.39 | -- | -- | 11.05 | -- | -- | 80.65 | -- | 112.46 | -- | -- | -- |
| Kopran Ltd | 6.20bn | 165.43m | 6.45bn | 1.02k | 39.14 | -- | 19.33 | 1.04 | 3.41 | 3.41 | 128.28 | -- | -- | -- | -- | 6,052,426.00 | -- | 7.85 | -- | 11.25 | 34.20 | 32.04 | 2.67 | 8.66 | -- | 2.39 | -- | 29.60 | 2.44 | 11.86 | -24.34 | 12.90 | 33.20 | -- |
| Fabtech Technologies Ltd | 3.87bn | 313.94m | 7.15bn | -- | 16.27 | -- | 19.84 | 1.85 | 9.89 | 9.89 | 115.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.01 | -- | 8.11 | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Accent Microcell Ltd | 2.78bn | 346.64m | 7.69bn | 192.00 | 21.03 | 3.08 | 19.76 | 2.77 | 15.24 | 15.24 | 122.20 | 104.07 | 1.12 | 4.14 | 5.32 | 14,474,330.00 | 13.99 | -- | 15.95 | -- | 39.96 | -- | 12.47 | -- | 3.01 | 76.48 | 0.0046 | -- | 7.77 | -- | 9.60 | -- | -- | -- |
| Remus Pharmaceuticals Ltd | 7.48bn | 325.59m | 7.70bn | 68.00 | 21.01 | 2.51 | 17.51 | 1.03 | 31.11 | 31.11 | 701.20 | 260.51 | 1.89 | 9.07 | 7.21 | 109,981,700.00 | 10.44 | 14.37 | 18.44 | 28.60 | 13.01 | 19.39 | 5.51 | 8.39 | 1.07 | 35.59 | 0.0452 | 3.59 | 191.93 | 120.44 | 34.98 | 104.56 | 48.07 | -- |
| Anuh Pharma Ltd | 7.68bn | 418.22m | 8.13bn | 295.00 | 19.42 | -- | 15.34 | 1.06 | 4.17 | 4.17 | 76.65 | -- | -- | -- | -- | 26,023,040.00 | -- | 10.41 | -- | 17.00 | 22.25 | 23.95 | 5.45 | 7.35 | -- | 116.27 | -- | 26.59 | 2.24 | 16.60 | -21.16 | 27.05 | -10.78 | 16.89 |
| Themis Medicare Ltd | 3.41bn | -269.80m | 8.39bn | 1.76k | -- | 2.21 | -- | 2.46 | -2.92 | -2.92 | 37.53 | 41.29 | 0.5758 | 1.78 | 1.82 | 1,937,953.00 | -4.55 | 10.17 | -6.33 | 14.38 | 63.17 | 60.61 | -7.91 | 13.52 | 1.28 | -1.55 | 0.201 | 9.36 | 6.22 | 15.00 | -31.46 | 3.78 | 21.58 | 23.36 |
| Sigachi Industries Ltd | 5.06bn | -550.46m | 8.53bn | 1.10k | -- | 1.68 | -- | 1.69 | -1.46 | -1.46 | 13.20 | 13.29 | 0.6316 | 2.40 | 2.80 | 4,624,222.00 | -6.70 | 12.29 | -9.77 | 16.21 | 52.83 | 51.93 | -10.62 | 14.80 | 1.27 | 5.53 | 0.2436 | 4.23 | 22.38 | 28.55 | 21.66 | 27.91 | 48.87 | -- |
| Wanbury Ltd | 6.58bn | 646.86m | 8.83bn | 1.38k | 13.21 | -- | 11.16 | 1.34 | 19.13 | 19.13 | 194.16 | -- | -- | -- | -- | 4,758,967.00 | -- | 8.87 | -- | 101.40 | 55.07 | 41.82 | 9.84 | 5.62 | -- | 2.97 | -- | -- | 4.15 | 10.29 | -45.44 | -13.88 | 44.32 | -- |
| Venus Remedies Ltd | 7.00bn | 762.95m | 9.86bn | 1.30k | 12.91 | -- | 9.87 | 1.41 | 57.10 | 57.10 | 523.77 | -- | -- | -- | -- | 5,391,957.00 | -- | 6.67 | -- | 8.08 | 47.02 | 37.62 | 10.90 | 6.87 | -- | 1,849.19 | -- | -- | 7.72 | 13.81 | 59.05 | -- | 18.36 | -- |
